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Abstract
Background: Internet-based guided self-help is efficacious for panic disorder, but it is not known whether such treatment is
effective for milder panic symptoms as well.
Objective: To evaluate the effectiveness of Don’t Panic Online, an Internet-based self-help course for mild panic symptoms,
which is based on cognitive behavioral principles and includes guidance by email.
Methods: A pragmatic randomized controlled trial was conducted. Participants (N=126) were recruited from the general
population and randomized to either the intervention group or to a waiting-list control group. Inclusion criteria were a Panic
Disorder Severity Scale-Self Report (PDSS-SR) score between 5-15 and no suicide risk. Panic symptom severity was the primary
outcome measure; secondary outcome measures were anxiety and depressive symptom severity. Measurements were conducted
online and took place at baseline and 12 weeks after baseline (T1). At baseline, diagnoses were obtained by telephone interviews.
Results: Analyses of covariance (intention-to-treat) showed no significant differences in panic symptom reduction between
groups. Completers-only analyses revealed a moderate effect size in favor of the intervention group (Cohen’s d=0.73, P=.01).
Only 27% of the intervention group finished lesson 4 or more (out of 6). Nonresponse at T1 was high for the total sample (42.1%).
Diagnostic interviews showed that many participants suffered from comorbid depression and anxiety disorders.
Conclusions: The Internet-based guided self-help course appears to be ineffective for individuals with panic symptoms. However,
intervention completers did derive clinical benefits from the intervention.
Trial Registration: Nederlands Trial Register: NTR1639; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1639
(Archived by WebCite at http://www.webcitation.org/6ITZPozs9).
(J Med Internet Res 2013;15(7):e154)   doi:10.2196/jmir.2362
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Introduction
Panic disorder (PD) with or without agoraphobia is a prevalent
anxiety disorder associated with substantial loss of quality of
life for the patient and considerable costs to society [1-4].
Subclinical PD, defined as panic symptoms that do not meet
full Diagnostic and Statistical Manual of Mental Disorders
(Fourth Edition; DSM-IV) criteria for PD, is just as prevalent
[2,4]. Subclinical panic symptoms can develop into clinical PD
and are also a predictor for the development of mental disorders
other than PD, such as generalized anxiety disorder, social
phobia, or major depressive disorder (MDD) [5].
For treatment, PD can be effectively treated with psychological
or drug therapy [6-8]. Research indicates that it is also possible
to prevent or delay the onset of clinical PD in people with
subclinical panic symptoms [9,10]. A recent study showed that
a group intervention involving primarily cognitive behavioral
therapy effectively reduced symptoms in subclinical cases of
PD, as well as in relatively mild cases [10]. This group course,
called Don’t Panic, could also be acceptable from a
cost-effectiveness point of view [11].
Internet-based guided self-help has shown to be an efficacious
treatment of PD as well, with a large effect size (Hedge’s
g=0.83) [12]. To date, all but 1 study [13] comparing
Internet-based guided self-help for PD with a control condition
have focused purely on groups with clinical PD, which
commonly was also the primary diagnosis (eg, [14,15]). These
studies excluded subclinical cases (eg, [14-16]). Recently, an
Internet-based version of the group course Don’t Panic has been
developed. This intervention, Don’t Panic Online, is an
Internet-based self-help course with minimal guidance
specifically for individuals with mild panic symptom severity.
The aim was to provide an accessible, low-intensity, early
intervention for panic symptoms.
The current study is a pragmatic randomized controlled trial
(RCT) of the effectiveness of Don’t Panic Online in reducing
panic and anxiety symptoms among participants with subclinical
and mild clinical PD. We postulate a difference in effect between
Don’t Panic Online and a waiting-list control group.
Methods
Design
We conducted a pragmatic RCT with 2 arms: (1) Internet-based
guided self-help, and (2) a waiting-list control group (see
subsequent description). The Medical and Ethical Committee
of VU University Medical Center approved the study protocol,
which is described in greater detail elsewhere [17]. This paper
was written in accordance with the CONSORT-EHEALTH
checklist [18], and this trial has been registered in the
Netherlands Trial Register (NTR1639). The Netherlands Trial
Register is part of the Dutch Cochrane Centre.
Study Population
We included participants aged 18 and older, with subclinical
PD or clinical PD with relatively mild symptom severity, who
had access to the Internet. Any individuals who were at risk of
suicide were excluded. Subclinical or mild PD was defined as
having a score ranging from 5 to 15 on the Panic Disorder
Severity Scale-Self Report (PDSS-SR) [19]. These cut-off points
represent slight to moderate panic symptom severity [20]. No
restrictions were imposed on the use of pharmacotherapy or
psychotherapy.
Sample Size
Previous RCTs of Internet-based self-help interventions for
panic symptoms showed large between-group effect sizes [12].
Our aim was to recruit participants with milder symptom
severity than those who took part in these studies. Therefore,
our sample was expected to show a smaller decrease in panic
symptoms. Based on a moderate effect size (Cohen’s d [d]=
0.50), and using a 2-sided t test (alpha = .05, power 80%) to
compare the PDSS-SR scores of the intervention group with
those of the control group, we aimed to include 128 participants
[21], with 64 in each group. Any missing values at posttreatment
were imputed.
Recruitment
Participants were recruited from the general population. Most
of those who applied for participation did so after reading about
this study in the health section of an online newspaper.
Additional online recruitment was conducted by means of a
Facebook advertising campaign and by posting messages on
panic-related or anxiety-related message boards. This was
supplemented by offline recruitment by means of advertisements
in national newspapers and articles in local newspapers.
Interested individuals were directed to a study website, where
they could find information about participation and a
downloadable informed consent form. The application procedure
involved printing and signing the informed consent form, then
sending this to the research team (either as a physical document,
by conventional mail, or as a scanned document attached to an
email).
Randomization and Procedure
Consenting applicants were sent an email with a link to the
online questionnaires. The baseline (T0) questionnaires included
the screening questionnaires for inclusion. Any participants
who reported severe panic symptoms or who were at risk of
suicide were sent an automatic message advising them to contact
their general practitioner and/or to visit a website for suicide
prevention. This website [22] offers psychoeducation and a
helpline by telephone or online chat [23]. Those participants
who had completed T0 and who met the inclusion criteria were
contacted within 2 weeks for a diagnostic interview by
telephone. This interview was used to obtain a more detailed
overview of the study sample, not for the purposes of inclusion
or exclusion. After the interview, all participants were
randomized to 1 of the 2 groups. Randomization was stratified
for the presence or absence of agoraphobic symptoms (PDSS-SR
item 4 score ≥2) and the use of antidepressants or sedatives.
Randomization lists were generated automatically using a
computer program. The T0 measurement can be considered to
be double blind because the participants were not randomized
until they had completed all of the questionnaires and the
diagnostic interview. Blinding of the participants at
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posttreatment assessment (T1) was not possible because at that
stage they were aware of the nature of the group to which they
had been allocated. T1 was scheduled 12 weeks after the
baseline assessment. Both T0 and T1 were self-reported and
were conducted through the Internet. Any participants who had
not completed T0 or T1 were sent up to 3 automated reminders
by email at weekly intervals.
Intervention
Don’t Panic Online is a guided, Internet-based, individual,
self-help course, based on cognitive behavioral therapy
principles. The course consists of 6 sessions in which the
participants learn to control their panic symptoms by applying
various cognitive and behavioral techniques and skills. The
course’s content is described in more detail elsewhere [17]. A
typical lesson takes approximately 30 minutes and consists of
an introduction, a discussion of the previous lesson’s homework,
new theory, and homework for the following week. A
track-and-trace system keeps a record of the dates on which
participants log on and complete a lesson. The participants in
the intervention group were coached by trained, Master’s-level
clinical psychology students. Every week, these participants
received an email from their coach, asking how they were doing
and whether they were experiencing any difficulty in following
the program. The coaches responded to questions about the
course and the associated exercises. They also gave brief replies
to questions about the participant’s mental health. The coaches
were supervised by the first author. On average, the total time
spent on each participant was 1 to 2 hours.
Participants in the control group received access to Don’t Panic
Online after completing the T1 measurement (12 weeks after
T0). While waiting, they had access to an information website
about the symptoms of panic and agoraphobia. This website
included advice to contact a general practitioner in case the
participant had further questions about panic symptoms and its
treatment. All participants in the control group and the
intervention group were free to seek any (additional) help they
might require.
Instruments
The following variables were measured: demographic data,
DSM-IV diagnosis, symptoms of anxiety and panic, depressive
symptoms, and suicide risk. All variables were measured at
both T0 and T1, except for demographic data, diagnosis, and
suicide risk, which were only measured at T0.
The T0 measurement started with demographic questions. These
included age, gender, place of birth, marital status, education
level, physical health, and previous mental health diagnoses.
The Composite International Diagnostic Interview (CIDI)
12-month prevalence [24] was used to ascertain the presence
or absence of PD, other anxiety disorders, and depression. A
clinical diagnosis was made, not as an inclusion criterion, but
to gain a more complete overview of the participants. The CIDI,
which was developed by the World Health Organization, is an
extensive, fully structured, diagnostic interview to assess
DSM-IV Axis-I diagnoses [24]. The only subscales used were
depression, PD, agoraphobia, generalized anxiety disorder,
social phobia, and posttraumatic stress disorder. In this study,
a trained interviewer administered the CIDI by telephone.
The severity of current panic symptoms was measured using
the PDSS-SR. The PDSS, which was originally designed as a
face-to-face interview for both research and clinical practice
[25], was adapted to be used in a patient self-report format [19].
The instrument contains 7 items that assess the severity of 7
dimensions of PD and its associated symptoms. The PDSS-SR
generates a total score ranging from 0 to 28. The higher the
score, the more severe the panic symptoms. The questionnaire
has adequate psychometric properties when compared with the
PDSS [19,26]. For the purposes of the current study, a score of
less than 5 indicates that there are no clinically significant
symptoms, whereas a score of more than 15 is interpreted as
severe PD. Therefore, our study focused on the group with
scores ranging from 5 to 15. According to the study by
Furukawa et al [20], this score range identifies participants with
mild to moderate panic symptoms but excludes those without
panic symptoms as well as those with severe panic symptoms.
Anxiety symptoms in general were measured using the Beck
Anxiety Inventory (BAI) [27]. The BAI contains 21 short
questions. Convergent and divergent validity is sufficient
[28,29]. The score ranges from 0 to 63. A score of 30 or more
is considered to correspond to severe anxiety symptoms.
Depressive symptoms were measured using the Center for
Epidemiologic Studies Depression scale (CES-D) [30]. The
CES-D is a 20-item self-report questionnaire. The score of each
individual item ranges from 0 to 3, whereas the total score
ranges from 0 (no feelings of depression) to 60 (severe feelings
of depression). Convergent validity of the online Dutch version
for adults with other depressive measures is good [31]. With a
cut-off score of 22 for MDD, it also has good predictive validity
[31].
Suicide risk and suicidal ideation were measured using the
specific section of the Mini-International Neuropsychiatric
Interview (MINI) [32,33]. The MINI suicide section consists
of 6 items and classifies participants into categories ranging
from no suicide risk to high suicide risk. Any individuals with
a moderate to high suicide risk were excluded from this study.
In the current study, these items were administered online and
presented as self-report items.
An indication of health care services usage during the past
month was obtained using Part I of the Trimbos and Institute
of Medical Technology Assessment Questionnaire on Costs
Associated with Psychiatric Illness (TiC-P) [34].
Finally, the T1 battery of online questionnaires included open
questions concerning the participant’s subjective experience
with Don’t Panic Online and reasons for not finishing the
program. These questions were only administered to the
intervention group.
Analyses
Firstly, means and standard deviations were calculated for age
and symptom severity of panic, anxiety, and depression. Any
differences in symptom severity between the intervention group
and control group were expressed in terms of Cohen’s d (see
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subsequent description) to give an indication of the magnitude
of the difference in question.
Between-group effects at T1 were calculated using analyses of
covariance (ANCOVA), controlling for pretreatment scores.
Instead of F values, t values of parameter estimates are reported
because only 2 groups are compared (where t2 = F). Effect sizes
on continuous measures were expressed in terms of Cohen’s d,
which was calculated by and dividing the mean difference
between the 2 mean scores by the pooled standard deviation:
(mean1–mean0)/SDPooled. Effect sizes of 0.8 can be assumed to
be large, whereas effect sizes of 0.5 are moderate and effect
sizes of 0.2 are small [21]. Because Cohen’s d does not take
covariance into account, partial η2 is also reported in this paper.
It cannot be estimated which level of partial η2 could be
considered adequate because this effect size is dependent on
several factors. Within-group effects were analyzed using
paired-sample t tests and expressed in terms of Cohen’s d in
which the correlation between T0 and T1 was taken into account
by applying Morris and DeShon’s equation 8 [35]. Finally, the
proportion of participants below the PDSS-SR cut-off points
for clinical and subclinical PD was calculated for both T0 and
T1. We used the cut-off points of 8 and 5, indicating clinical
PD [25] and subclinical PD [20], respectively. All analyses were
conducted for the full sample, for the subgroup completers, and
for subgroups with and without the diagnosis of PD according
to the CIDI. We maintained a 2-sided alpha of .05. For all
analyses, SPSS version 17 (SPSS Inc, Chicago, IL, USA) was
used.
The data were analyzed in agreement with the intention-to-treat
(ITT) principle. Missing data at T1 were imputed by multiple
imputation, in which all variables except for nominal variables
(ie, age, education level, clinical diagnoses, and symptom
severity on all measures at T0 and T1) were included as
predictors. Ten datasets were generated and analyses were
performed using pooled data. Compared with single imputation
methods, multiple imputation generates a more conservative
estimate of the sample standard error [36] and overestimation
of effect sizes and P values is unlikely. For the purpose of
sensitivity analysis, P values and effect sizes were also estimated
by running the Expectation Maximization (EM) algorithm [37]
on the missing data.
Results
Sample
Of 368 applicants who applied and sent in informed consent
forms, 126 were included in the study. See Figure 1 for a
flowchart and an overview of excluded applicants. The
participants were primarily female (85/126, 67.5%), born in the
Netherlands (115/126, 91.3%), with a mean age of 36.6 years
(SD 11.4, range 18-67), and 50% had a bachelor’s degree or
higher (Table 1). Diagnostic interviews showed that 97 (77.0%)
of the included participants met the criteria for PD with or
without agoraphobia. Other DSM-IV anxiety disorders and MDD
were also prevalent (Table 1). Five participants (4.0%) did not
meet the criteria for a diagnosis of a mood or anxiety disorder.
The control group had slightly higher baseline scores than the
intervention group (Table 1), but there were no to little further
differences between the intervention group and control group.
Details of health care services usage (eg, visits to the general
practitioner) are presented in Table 2. Approximately half of
the participants reported having consulted a general practitioner
in the month immediately prior to the study, and one-third had
seen a psychologist or psychiatrist.
Study Dropout
The posttreatment measurement was completed by 73
participants (57.9%). There was no significant difference
between the measurements and characteristics of these 73 study
completers and those of the 53 participants who were lost to
follow-up. However, within the intervention group, study
dropouts were less likely to have completed lessons 1 to 4 of
the course (χ21 = 15.1, P<.001).
Intervention Adherence
Of the 63 participants in the intervention group, 60 (95%) started
lesson 1, whereas 3 participants did not log in at all (Figure 1).
Approximately half of the participants (31/63, 49%) completed
lesson 2. Five participants (8%) finished all 6 modules of Don’t
Panic Online, 4 (6%) of them within the given 3-month time
frame. During the trial, 3 participants (5%) reported that they
experienced difficulties accessing the website. Those participants
in the intervention group who completed T1 but did not
complete the intervention (n=30) were asked why they dropped
out. The most frequently reported reasons involved time
constraints (n=13), life events (n=5), and symptoms so severe
that the individual was unable to follow the program (or parts
thereof) or carry out the assignments (n=5; see Table 3).
Intention-to-Treat Analyses
After multiple imputation, ANCOVAs showed no significant
difference in panic symptom severity at T1 between groups as
measured by the PDSS-SR (t = –1.17, P=.25, partial η2 = .023,
d=0.30; Table 4). The within-group difference of the
intervention group was significant (t=3.06, P=.007, d=0.62), as
was the within-group difference of the control group, albeit with
a smaller effect size (t=2.26, P=.03, d=0.40). The mean BAI
score did not differ between groups (t = –1.71, P=.09, partial
η2 = .027, d=0.39; Table 4). Nor were there any differences
between groups in terms of depressive symptoms, as measured
by the CES-D (t = –1.56, P=.12, partial η2 = .034, d=0.39; Table
4).
At T1, and with missing values imputed, 24 participants (38%)
in the intervention group and 13 (20%) in the control group had
PDSS-SR scores of less than 5 (ie, symptom free). This
difference did not reach significance (χ2 = 5.7, P=.07). With
regard to the cut-off point of 8 (the recommended cut-off for
clinical diagnosis), 28 participants (44%) in the intervention
group and 22 (35%) in the control group scored below 8 at T0.
At T1, 38 participants in the intervention group (60%) and 33
participants in the control group (52%) scored below 8, a
nonsignificant difference (χ2 = 1.3, P=.43).
Sensitivity analyses with the EM algorithm gave slightly
different results. There was no significant effect between groups
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on the primary outcome measure (PDSS-SR: t124 = –1.79, P=.08,
partial η2 = .025, d=0.34), but the difference in BAI anxiety
symptoms did reach significance (t124 = –2.33, P=.02) with a
moderate effect size (d=0.46, partial η2 = .042). CES-D
depressive symptoms also differed between groups (t124 = –2.69,
P=.008) with a moderate effect size (d=0.47, partial η2 = .055).
Table 1. Baseline characteristics of participants.
Difference at base-
line (Cohen’s d)
Control group
n=63
Intervention group
n=63
Total sample
N=126
Characteristics
Demographics
36.4 (10.7)36.7 (12.2)36.6 (11.4)Age, mean (SD)
41 (65.1)44 (69.8)85 (67.5)Female, n (%)
58 (92.1)57 (90.5)115 (91.3)Born in the Netherlands, n (%)
27 (42.9)23 (36.5)50 (39.7)Living alone, n (%)
33 (52.4)30 (47.6)63 (50.0)High education,a n (%)
4 (6.3)5 (7.9)9 (7.1)Physical health problems, n (%)
25 (39.7)22 (34.9)47 (37.3)Previously diagnosed with a mental disorder,
n (%)
Diagnoses, b n (%) c
31 (49.2)30 (47.6)61 (49.2)PD with agoraphobia
19 (30.2)17 (27.0)36 (29.0)PD without agoraphobia
7 (11.1)10 (15.9)17 (13.7)Agoraphobia without PD
6 (9.5)5 (7.9)11 (8.9)GAD
39 (61.9)39 (61.9)78 (62.9)Social phobia
12 (19.0)4 (6.3)16 (12.9)PTSD
26 (41.3)27 (42.9)53 (42.7)MDD
Symptom severity, mean (SD)
0.129.1 (2.8)8.8 (3.2)8.9 (3.0)Panic (PDSS-SR)
0.2226.0 (11.3)23.7 (10.2)24.9 (10.8)Anxiety (BAI)
0.1821.6 (9.0)20.0 (9.1)20.8 (9.0)Depression (CES-D)
aDefined as the equivalent of a bachelor’s degree or higher.
bPercentages add up to more than 100% due to comorbid diagnoses.
cMissing data of 2 participants (n=124).
Table 2. Use of care in the past month.
T1,a n (%)T0, n (%)Care use
Control group
(n=39)
Intervention group
(n=16)
Control group
(n=63)
Intervention group
(n=63)
12 (31%)2 (13%)31 (49%)27 (43%)Visited general practitioner
14 (36%)5 (31%)17 (27%)23 (37%)Visited psychologist or psychiatrist
14 (36%)3 (19%)25 (40%)18 (29%)Visited other professional health care giver
13 (33%)7 (44%)23 (37%)20 (32%)Used antidepressants, sedatives, or sleeping pills
aDifferences within groups and between groups did not reach significance.
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Figure 1. Flow of participants through the study.
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Table 3. Reasons why participants did not finish Don’t Panic Online within 12 weeks (n=30).
naReason for discontinuation
13Time constraint (too busy or need more time)
5Life events (pregnancy, loss, family issues)
5Symptoms too severe to do assignments
4Found other therapy
3Content not applicable
2Spontaneous recovery
1Adverse effect
1More guidance needed
1Lack of structure
1Lessons too slow
1Not motivated
aNumbers do not add up to 30 because 2 participants did not give reasons and others gave several.
Table 4. Differences between groups at T1, intention-to-treat (N=126).
Between-groups effectaGroup, mean (SD)aMeasure
ANCOVAb
Cohen’s d
(95% CI)
Control group
(n=63)
Intervention group
(n=63)
Partial η2Pt c
.023.25–1.170.30 (–0.91, 1.51)7.3 (4.9)5.8 (4.9)PDSS-SR
.027.09–1.710.39 (–2.74, 3.53)22.0 (12.7)17.0 (12.7)BAI
.034.12–1.560.39 (–2.59, 3.42)21.1 (12.1)16.4 (12.3)CES-D
aMissing data imputed by multiple imputation.
bControlling for symptom severity at T0.
cDegrees of freedom not provided due to multiple imputation.
Completers-Only Analyses
Those participants in the intervention group who had completed
the first 4 lessons (or more) of the course (n=17) were included
in the completers-only analyses. These completers cannot be
all considered to have completed the intervention, but after 4
lessons, participants can be considered to have experienced
most of the content of the intervention. Sixteen of the 17
participants in the intervention group who had completed the
first 4 lessons also filled in T1 questionnaires. Accordingly,
there were 16 completers in the intervention group. These 16
individuals did not significantly differ from the noncompleters
in the intervention group at T0 in terms of age, education,
clinical diagnosis, and symptom severity. Control group
completers were those who filled in T1 (n=39).
The ANCOVA showed significant differences between the
intervention group completers and control group completers
with regard to panic symptom severity at T1 (t53 = –2.60, P=.01,
d=0.73; see Table 5), in favor of the intervention group. The
intervention group was also characterized by a large
within-group effect on panic symptoms (t15 = 4.92, P<.001,
d=1.23). In the control group, within-group effects did not reach
significance. ANCOVA also showed that BAI anxiety symptom
severity differed significantly between groups (t53 = –2.37,
P=.02, d=0.60, see Table 5), as did depressive symptom severity,
as measured using the CES-D (t53 = –2.52, P=.02, d=.94).
Ten (68%) of the intervention completers and 8 (21%) of the
control group completers had a PDSS-SR score of less than 5
at T1, which is a significant difference (χ21 = 9.1, P=.003). In
terms of the cut-off point for clinical diagnosis, 13 participants
in the intervention group (81%) and 23 (59%) in the control
group scored less than 8, but this difference did not reach
statistical significance (χ21 = 2.5, P=.12).
Lastly, health care service usage rates did not differ either within
or between groups (see Table 2).
Participants With Diagnosis of Panic Disorder Versus
Those Without Diagnosis
Neither ITT nor completers-only analyses showed differences
on any outcome measure between participants with and without
clinical PD.
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Table 5. Differences between groups at T1, completersa (n=55).
Between-groups effectGroup, mean (SD)Measure
ANCOVAb
Cohen’s d
(95% CI)
Control group
(n=39)
Intervention group
(n=16)
Partial η2Pt 53
.115.01–2.600.73 (–0.60, 2.32)7.5 (4.2)4.6 (3.3)PDSS-SR
.098.02–2.370.60 (–2.93, 7.15)22.6 (11.2)15.6 (13.4)BAI
.109.02–2.520.94 (–2.50, 5.10)21.6 (11.0)12.1 (8.5)CES-D
aControl group completers are those who provided posttreatment data. Intervention group completers are those who provided posttreatment data and
completed at least lesson 4.
bControlling for symptom severity at T0.
Discussion
Overview
This study showed that the Internet-based, guided, self-help
intervention Don’t Panic Online was not effective in individuals
with panic symptoms. Completers-only analyses did show
moderate to large effect sizes between groups in favor of the
intervention group. Adherence to the treatment was low. An
analysis of the data using a less conservative imputation method
revealed significant effects between groups in terms of the scores
for general anxiety and depressive symptoms, but not for panic
symptoms. Overall, the results show that Don’t Panic Online
could be efficacious for intervention completers, but that it is
not generally effective.
Comparison With the Literature
A meta-analysis revealed that the psychological treatment
(offline and online) of full-blown PD is highly effective
compared to a waiting-list control group, with a mean effect
size of d=1.19 [8]. Samples in which more than 50% of the
participants had comorbid disorders did not benefit as much,
but they still showed a large effect size even when compared
with pooled active and nonactive control groups (d=0.83) [8].
Self-help interventions have an average effect size of d=0.75,
again when compared with pooled control groups [8]. The
results of our completers-only analyses are in-line with these
findings. Treatment adherence is not reported in this
meta-analysis, only study dropout rates, which averaged 9.53%
for intervention groups.
For study design and intervention, our study is comparable with
the trial of Meulenbeek et al [10]. That study found a moderate
effect size of d=0.68 for the face-to-face group course Don’t
Panic, an intervention with similar content to Don’t Panic
Online. Treatment completion, defined as having followed at
least 6 of the 8 sessions, was 75%. In that study, the participants
had a relatively low baseline mean PDSS-SR score (7.2), which
is similar to our study’s findings. Aside from panic symptoms,
however, the sample differed from ours in a number of ways.
Meulenbeek et al excluded participants with severe disorders
other than PD, as well as those with social problems, and those
who were receiving treatment for panic symptoms. In general,
group interventions are no more effective than guided self-help
interventions [38]. Possibly, any differences in outcome between
the trials of Don’t Panic and Don’t Panic Online might be
attributed to inclusion criteria.
Previous studies that compared Internet-based guided self-help
for panic symptoms with a control group showed an overall
effect size of Hedge’s g=0.83 [12]. Similar to Don’t Panic
Online, the interventions studied were based on cognitive
behavioral therapy and were similar in length [14-16]. Compared
with these studies, effect sizes in the current study were expected
a priori to be lower. We included a less severe group, thereby
ruling out large decreases in symptom severity. Accordingly,
assuming that there was no deterioration in the control group,
the difference between the intervention group and control group
at T1 could not be as large. With regard to low treatment
adherence, this was not found in previous studies and values
ranged from 79% to 95% [12,15].
There are several differences between our study and previous
studies that may have had an impact on adherence. Firstly, all
participants in our trial were free to use medication and find
other treatment. Some may have found other help and decided
to quit Don’t Panic Online. Secondly, our participants reported
difficulties accessing the website. Thirdly, previous researchers
had more telephone contact with their participants [14,15]. Our
participants were also not interviewed after the treatment,
whereas a scheduled interview after treatment may have led to
better adherence [39]. Fourthly, the intervention we studied was
not the same as the interventions of other studies. Perhaps Don’t
Panic Online is not as effective or attractive as those examined
in other studies. Lastly, our sample included a large proportion
of participants with comorbid disorders, and possibly a
proportion of participants who did not have PD as primary
diagnosis. Perhaps an Internet-based intervention specifically
for panic symptoms is less suited to this group. However,
epidemiological data show that panic symptoms often coincide
with psychiatric disorders other than PD [2,4]. Therefore, the
participants of our study appear to be a representative sample
of individuals with panic symptoms.
In summary, both clinical effect and treatment adherence were
lower in our study than in previous studies of Internet-based
self-help interventions and the Don’t Panic group course. The
differences in sample characteristics between our study and
previous trials could indicate that Internet-based interventions
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for panic symptoms are efficacious, but they may not be
effective for all individuals seeking help for panic symptoms.
Limitations
When interpreting our results, several limitations should be
taken into account. One limitation of this study is nonresponse
at the posttreatment measurement. For a large proportion of
participants, it is unknown whether their panic symptoms
increased, decreased, or remained stable. These missing values
were estimated by multiple imputation. Although this can be
considered a conservative imputation method, it is unlikely that
the imputed values greatly underestimate the intervention effect.
This is because many of the participants who did not respond
at T1 also left the intervention after 1 or 2 sessions, and are,
therefore, unlikely to have gained much benefit from it. A
second limitation is that the intervention completers are small
in number and may not be representative of the intervention
group as a whole, even though there did not appear to be
significant differences between completers and noncompleters.
The comparison of this select group with the control group, for
completers-only analyses, should be interpreted with caution.
Thirdly, the control group could have had gained some benefit
from the information website, which could have decreased the
difference between T1 mean scores of the intervention group
and control group. If that is the case, our study proved that Don’t
Panic Online has, in general, no added value compared with an
information website and our conclusion would remain the same.
A fourth limitation is the lack of a follow-up measurement. It
is not known whether the participants in either the intervention
group or the control group showed any further improvement
over the subsequent months to a year. Finally, all continuous
measures were obtained by online self-report. The PDSS-SR
could potentially yield lower mean scores than the PDSS
interview [26], whereas online versions of questionnaires could
potentially yield higher mean scores than pencil-and-paper
versions [40,41]. These differences in psychometric properties
limit the comparison of this study with other studies. However,
this imposes no restrictions on comparisons between the
intervention group and control group within our own study and,
additionally, online and pencil-and-paper versions of panic
questionnaires do appear to be equivalent [42,43].
Implications and Future Research
Although previous research indicates that Internet interventions
can be an efficacious treatment of panic symptoms, our results
may suggest that a linear program targeting specific symptoms
is not always effective. As our study and others have shown,
panic symptoms generally coincide with comorbid symptoms.
Therefore, transdiagnostic and tailorable interventions could be
a future direction of Internet-based treatment of panic.
Internet-based transdiagnostic self-help programs, tailored to
the anxiety and/or depressive symptoms of the participant, show
promising results in terms of the treatment of panic and other
common mental disorders [13,44,45]. Tailored interventions
could be more effective for individuals with higher symptom
severity and comorbidity rates than nontailored programs [46].
Tailoring might help to increase treatment adherence because
participants would then only see those sections that are
applicable to them. Given the results of our study, the further
development of transdiagnostic and tailorable Internet
interventions should be encouraged.
Future research could focus on identifying those groups for
whom Internet-based self-help interventions are effective, for
example, by means of predictor and mediator analyses. Further
research is also needed to investigate ways of boosting treatment
adherence to Don’t Panic Online, of making it a feasible
intervention for mild to moderate panic symptoms, and perhaps
of modifying it to become more tailored and transdiagnostic in
nature. This was the first study of Internet-based guided self-help
for mild panic symptoms and our study needs to be replicated
before we can draw any definitive conclusions. Lastly, although
the efficacy of Internet-based guided self-help interventions has
been established in several studies, it should be encouraged to
conduct more pragmatic RCTs to examine the effectiveness.
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